Cullinan Oncology LLC
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -77 | -76 | ||
EBITDA | -54,971 | -48,779 | -49,950 | -42,913 |
EBIT | -55,048 | -48,855 | -50,027 | -42,989 |
Net Income | -47,647 | -40,560 | -42,028 | -37,148 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -36,626 | -34,139 | -36,291 | -38,247 |
Cash | 83,005 | 102,085 | 115,021 | 74,228 |
Basic Shares | 58,580 | 58,337 | 55,052 | 43,011 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $18,943 |
Gross Profit | -310 | -93 | 18,943 | |
EBITDA | -190,339 | 151,409 | -67,901 | |
EBIT | -190,649 | 151,316 | -67,954 | |
Net Income | -167,383 | -153,162 | 111,214 | -65,040 |
Net Change In Cash | 0 | 0 | 0 | 18,943 |
Cost of Revenue | 96,378 | -108,424 | ||
Free Cash Flow | -145,303 | -134,483 | -127,797 | -44,022 |
Cash | 83,005 | 98,434 | 550,118 | 430,863 |
Basic Shares | 58,510 | 41,550 | 46,640 | 44,292 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.73 |
2024-09-30 | -$0.69 |
2024-06-30 | -$0.75 |
2024-03-31 | -$0.86 |
